SENSUS DRUG DEVELOPMENT CORPORATION – Trademark Portfolio
Entity Type: 03
SENSUS DRUG DEVELOPMENT CORPORATION holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SOMAVERT. The owner is based in AUSTIN,, TX.
SUITE 430
AUSTIN,, TX 78701
Showing of trademarks Trademarks
Trademark Classifications
SENSUS DRUG DEVELOPMENT CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SENSUS DRUG DEVELOPMENT CORPORATION have?
SENSUS DRUG DEVELOPMENT CORPORATION has 15 U.S. trademarks filed with the USPTO. Of these, 2 registered, 12 abandoned, 1 cancelled.
What trademark classes does SENSUS DRUG DEVELOPMENT CORPORATION file in?
SENSUS DRUG DEVELOPMENT CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SENSUS DRUG DEVELOPMENT CORPORATION's most well-known trademarks?
SENSUS DRUG DEVELOPMENT CORPORATION's registered trademark portfolio includes well-known marks such as SOMAVERT. These are among 2 currently registered trademarks in the portfolio.
What is SENSUS DRUG DEVELOPMENT CORPORATION's trademark registration success rate?
SENSUS DRUG DEVELOPMENT CORPORATION has a 13% trademark registration rate, with 2 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.